Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Research to Improve Treatments for Millions of Lung Disease Patients

By Monash University | August 9, 2016

New lung scanning technology developed at Monash University has the potential to transform treatment for millions of people with lung disease in Australia and around the world.

A four-dimensional lung scanning platform developed at Monash University by Professor Andreas Fouras has been commercialised by his medical technology company 4Dx. The scanning platform is now giving a Monash-led research team new insights into improved treatment.

Dr Rajeev Samarage, joint lead author from Monash’s Laboratory for Dynamic Imaging said the technology would potentially help millions of people.

“Monash has a long record of working with industry to apply deep research into practical commercial applications. With this technology, not only will clinicians have a clearer image of what is happening in the patient’s lungs, but it is our aim to detect changes in lung function much earlier than in the past, which will allow clinicians to quantify the effects of treatment by simply comparing measurements from one scan to the next,” said Dr Samarage.

Published in the international journal Scientific Reports, the research involved 4Dx, Monash University, the Women’s and Children’s Hospital South Australia, University of Heidelberg and University of North Carolina at Chapel Hill.

Chairman and CEO of 4Dx Professor Fouras said the 4Dx pre-clinical scanner generates high-resolution images of lung-tissue motion and airflow throughout the lungs, which allows investigators to view and measure abnormal function in specific areas of the lung, before a disease progresses and spreads.

“Current tools are out of date and require two or three pieces of diagnostic information to piece together what is happening in someone’s lungs. Our game-changing diagnostic tool offers images of the breathing lungs, making it possible to see what is really important – not what they look like – but how they work,” Professor Fouras said.

Professor Greg Snell, Head of Lung Transplant Service at the Alfred hospital said it was a significant step.

“This technology has great potential as a new tool for both early diagnosis and management of many very common lung conditions. I think this will be the start of a new way of thinking about diagnostic imaging.”

Cystic Fibrosis Victoria CEO Karin Knoester said it was an important tool to help people treat and manage their condition.

“Any tool that can identify damage at an early stage will be able to inform intervention, with the hope of reducing further damage.”

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE